^Heemskerk, J. W. M.; Mattheij, N. J. A.; Cosemans, J. M. E. M. Platelet-based coagulation: different populations, different functions. Journal of Thrombosis and Haemostasis. 2013, 11 (1): 2–16. ISSN 1538-7933. doi:10.1111/jth.12045.
扩展阅读
Bray PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization.. Thromb. Haemost. 1995, 72 (4): 492–502. PMID 7878622.
Charakida M, Tousoulis D, Stefanadis C, Toutouzas P. The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic disease.. Italian Heart Journal. 2003, 4 (1): 17–22. PMID 12690916.
Smith FB, Connor JM, Lee AJ, et al. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.. Thromb. Res. 2004, 112 (4): 209–16. PMID 14987913. doi:10.1016/j.thromres.2003.11.010.
Fullard JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis.. Curr. Pharm. Des. 2004, 10 (14): 1567–76. PMID 15134555. doi:10.2174/1381612043384682.
Cacciari B, Spalluto G. Non peptidic alphavbeta3 antagonists: recent developments.. Curr. Med. Chem. 2005, 12 (1): 51–70. PMID 15638730. doi:10.2174/0929867053363522.
Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets.. J. Thromb. Haemost. 2005, 3 (8): 1752–62. PMID 16102042. doi:10.1111/j.1538-7836.2005.01429.x.